297 results for Ways to Support

Refine Your Search

Exercise for blood cancer patients

Exercise for blood cancer patients

Table of contents:​​Exercise for Blood Cancer Patients​Why is being physically active important for blood cancer patients?​Goals of an exercise progra…

Leukemia vs. lymphoma: What you need to know

Leukemia vs. lymphoma: What you need to know

Table of contentsLeukemia vs. Lymphoma: What You Need to KnowWhat Is Leukemia?Organs Affected by LeukemiaWhat Is Lymphoma?Organs Affected by LymphomaD…

Key bill gains major traction in Congress, bringing children with cancer one step closer to faster care

Key bill gains major traction in Congress, bringing children with cancer one step closer to faster care

The House Energy and Commerce Committee unanimously passed the Accelerating Kids' Access to Care Act. It's a key step toward the bill becoming law and…

Healing Happens Around The Dinner Table

Healing Happens Around The Dinner Table

Too many parents lose their children to blood cancer each year. It’s a devastating experience for families blindsided by the harsh realities of cancer…

Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.

Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.

To commemorate both Myeloma Awareness Month and Women’s History Month during March, I’ve been talking with LLS-funded women scientists who are driving…

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Table of contents:What is Hodgkin lymphoma? Organs affected by Hodgkin lymphomaHodgkin lymphoma symptoms and early signsWhat is non-Hodgkin lymphoma?O…

MY FIRST 100 DAYS AS LLS PRESIDENT & CEO

MY FIRST 100 DAYS AS LLS PRESIDENT & CEO

Dear Friends, I’m just over 100 days into my new role as President & CEO of The Leukemia & Lymphoma Society (LLS) and I want to take this moment…

How to start accepting help

How to start accepting help

Keep the door openDon’t say no off the bat. When you’re asked how you are, or someone asks how they can help, you might find yourself reflexively answ…

What’s Next in Blood Cancer: Looking Ahead to 2023

What’s Next in Blood Cancer: Looking Ahead to 2023

We’ve come a long way and we continue to make substantial progress. The outlook for blood cancer patients is better than ever, but it’s still nowhere …

3 Insights from a Clinical Trial Patient

3 Insights from a Clinical Trial Patient

The road to finding new and better cancer treatments often includes an important step: clinical trials. For patients with hard-to-treat diseases, thes…

Blood Cancer Survivors Find Special Meaning and Connection as Employee Champions of LLS Light the Night Events

Blood Cancer Survivors Find Special Meaning and Connection as Employee Champions of LLS Light the Night Events

The Leukemia & Lymphoma Society (LLS) is proud of our continuing partnership with Gilead and Kite Oncology as the National Presenting Sponsor of Celeb…

Honoring My Daughter’s Legacy By Continuing Her Fight

Honoring My Daughter’s Legacy By Continuing Her Fight

Today is International Childhood Cancer Day, a day that had little significance for me less than four short years ago. In October 2017, I heard the wo…

Predisposing factors to leukemia

Predisposing factors to leukemia

Table of contents:Predisposing Factors to LeukemiaLeukemia CausesGenetic MutationsIs Leukemia Hereditary?Causes of Leukemia in AdultsCauses of Leukemi…

Feeling uncertain? Start here.

Feeling uncertain? Start here.

If you need information or support: There’s a lot to take in with a blood cancer diagnosis: medical realities, treatment options, and the sheer emotio…

Meet The Researcher: Dr. Rayne Rouce

Meet The Researcher: Dr. Rayne Rouce

To commemorate Black History Month, LLS is highlighting exceptional clinicians and healthcare professionals throughout the month of February. Dr. Rayn…

A race for blood cancer research

A race for blood cancer research

Caring about something makes you want to take action. To get moving. And when you care about people with blood cancer, you might feel that pull more u…

Bringing Together the CAR T-Cell Therapy Community

Bringing Together the CAR T-Cell Therapy Community

It’s easy to think of scientific researchers as existing in a vacuum: spending long days and evenings in a laboratory, making observations that most p…

A Starting Place to Prioritize Your Mental Health

Coping with a blood cancer diagnosis and the whirlwind of experiences that follows can be physically, mentally, and emotionally draining for everyone …

Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

We caught up with Gwen Nichols, MD, Chief Medical Officer at The Leukemia & Lymphoma Society (LLS), to share the progress we’re making to bring cures …

DIY: Your movement to cure blood cancer

Every dollar makes a difference. With Blood Cancer United DIY, you can turn any activity or event into a way to support the organiz…

Get Involved

How humor helped me with cancer

Let’s get something straight: dealing with cancer is serious. Whether you’re the one who’s gotten a diagnosis, or someone you care about has, there’s …

FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma

Chimeric Antigen Receptor (CAR) T cell-therapy is on a roll. Today marks the seventh approval of CAR T therapy since the first approval in 2017.

When The Time Comes: Katie & Phil’s Story

When The Time Comes: Katie & Phil’s Story

What do you do when your biggest fear comes true? It’s a reality that so many parents of children who have blood cancer face. The shift is abrupt. On…

Two Survivors Moving Mountains for Blood Cancer Care

Two Survivors Moving Mountains for Blood Cancer Care

A blood cancer diagnosis can feel like a mountain to climb—testing your stamina and willpower, challenging your body the longer you go on. But for sur…

New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma

Just one year after the first CAR T-cell treatment was approved for multiple myeloma, the second is about to hit the market. The FDA approved ciltacab…